Craig Rush: Clinical Trials

6 trials sponsored by Craig Rush, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 3 Phase 1, 2 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Early Phase 12Completed 2
Not applicable1Completed 1

Follow Craig Rush: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
Methamphetamine, Methylphenidate, Placebo oral capsule - Methamphetamine Use Disorder
Phase 1CompletedCraig Rush82019-09-012023-01-09
Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)
Alcohol, Placebos, Duloxetine (60 MG) - Alcohol Use Disorder
Phase 1CompletedCraig Rush192018-09-012026-06-09
Behavioral Effects of Drugs: Inpatient (35)
Cocaine, Placebo oral capsule, Methylphenidate - Cocaine Use Disorder
Early Phase 1CompletedCraig Rush92018-06-012019-06-25
Brief Online Interventions for Alcohol Use
Normative Feedback, Inhibitory Control Training, Working Memory Training - Alcohol Use Disorder
Not applicableCompletedCraig Rush4442018-02-222020-01-29
A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
Bupropion - Cocaine Use Disorders
Early Phase 1CompletedCraig Rush342013-01-012018-06-26
Aripiprazole to Reduce Cocaine Relapse
Aripiprazole, Placebos - Cocaine-Related Disorders
Phase 1CompletedCraig Rush412006-01-012017-04-06

Conditions studied

Alcoholism (2)  ·  Cocaine-Related Disorders (1)

Interventions

Methylphenidate (3)  ·  Duloxetine Hydrochloride (2)  ·  Aripiprazole (1)  ·  Bupropion (1)  ·  Cocaine (1)  ·  Ethanol (1)  ·  Lactose (1)  ·  Methamphetamine (1)

Countries

United States (6)

Top investigators

Craig R Rush, PhD (2)  ·  Craig R. Rush, PhD (1)  ·  Joshua A. Lile, PhD (1)  ·  Lon R. Hays, MD (1)  ·  Paul E Glaser, MD, PhD (1)

Results publications

PMID 30888705

NIH funding

R01AA026255 (1), R01DA020429 (1), R01DA032254 (1), R01DA047391 (1), R34DA038869 (1)